Delta-Fly Pharma(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4598/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/01/10 | 日証協 | 145,200株 | +4.16% | 79,300株 | +9999.99% | 136,684株 | -5.54% | 42,200株 | +9999.99% |
2019/12/30 | 日証協 | 139,400株 | -1.97% | 300株 | -96.51% | 144,701株 | -2.23% | 400株 | -98.77% |
2019/12/27 | 日証協 | 142,200株 | -3.33% | 8,600株 | +14.67% | 148,001株 | +0.7% | 32,529株 | +549.93% |
2019/12/20 | 日証協 | 147,100株 | -2.71% | 7,500株 | -55.36% | 146,972株 | +10.12% | 5,005株 | -85.58% |
2019/12/13 | 日証協 | 151,200株 | +3.99% | 16,800株 | +1020% | 133,467株 | +11.17% | 34,700株 | +3037.43% |
2019/12/06 | 日証協 | 145,400株 | -6.79% | 1,500株 | -75.81% | 120,061株 | -4.68% | 1,106株 | -87.57% |
2019/11/29 | 日証協 | 156,000株 | -7.42% | 6,200株 | -81.92% | 125,961株 | -5.4% | 8,900株 | -74.8% |
2019/11/22 | 日証協 | 168,500株 | +12.86% | 34,300株 | +170.08% | 133,146株 | +23.23% | 35,315株 | +209.78% |
2019/11/15 | 日証協 | 149,300株 | -5.21% | 12,700株 | -23.49% | 108,046株 | -4.16% | 11,400株 | +114.45% |
2019/11/08 | 日証協 | 157,500株 | -5.75% | 16,600株 | -60.57% | 112,740株 | -3.42% | 5,316株 | -75.19% |
2019/11/01 | 日証協 | 167,100株 | -2.79% | 42,100株 | -12.66% | 116,730株 | +5.68% | 21,425株 | -32.94% |
2019/10/25 | 日証協 | 171,900株 | +8.45% | 48,200株 | +169.27% | 110,455株 | +0.69% | 31,950株 | +103.5% |
2019/10/18 | 日証協 | 158,500株 | -1.37% | 17,900株 | -83.47% | 109,695株 | -0.36% | 15,700株 | -72.93% |
2019/10/11 | 日証協 | 160,700株 | +9.39% | 108,300株 | +246.01% | 110,095株 | +1.56% | 58,000株 | +491.84% |
2019/10/04 | 日証協 | 146,900株 | -2.84% | 31,300株 | +663.41% | 108,405株 | -1.27% | 9,800株 | +48.48% |
2019/09/27 | 日証協 | 151,200株 | -7.75% | 4,100株 | -84.53% | 109,805株 | -11.16% | 6,600株 | -70.67% |
2019/09/20 | 日証協 | 163,900株 | -13.29% | 26,500株 | -0.75% | 123,605株 | -0.72% | 22,500株 | -42.23% |
2019/09/13 | 日証協 | 189,010株 | +12.23% | 26,700株 | -63.43% | 124,505株 | +12.77% | 38,949株 | +323.36% |
2019/09/06 | 日証協 | 168,410株 | +1.72% | 73,010株 | +873.47% | 110,406株 | +2.13% | 9,200株 | +26.6% |
※株式分割は考慮していませんのでご注意ください。
Page Top